Effect of Surgicel (Fibrillar) on prevention for delayed bleeding after endoscopic submucosal dissection for gastric epithelial tumors

Effect of Surgicel (Fibrillar) on prevention for delayed bleeding after endoscopic submucosal dissection for gastric epithelial tumors - Effect of Surgicel (Fibrillar) on prevention for delayed bleeding after ESD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008214

Enrollment

157

Registered

2012-06-19

Start date

2012-12-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent ESD for gastric epithelial tumors

Interventions

Combination theratpy with Surgicel and H2RA Monotherapy with PPI

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will undergo ESD for gastric epithelial tumors

Exclusion criteria

Exclusion criteria: Patients who have disease with bleeding tendency

Design outcomes

Primary

Measure	Time frame
bleeding rates during follow up period after ESD	—

Countries

Asia(except Japan)

Contacts

Public ContactSu Jin Hong

Soonchunhyang University College of Medicine Digestive Disease Center, Department of Internal Medicine

sjhong@schmc.ac.kr82-32-621-5087

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026